HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

(5,6-dimethoxyindan-2-yl)dipropylamine

has 20-fold preference for D3 versus D2 dopamine receptors
Also Known As:
5,6-dimethoxy-2-(di-n-propylamino)indan; 5,6-dimethoxy-2-(dipropylamino)indan hydrochloride; PNU 99194A; PNU-99194A; U 99194; U 99194A; U-99194; U-99194A
Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Kizu, Tomoya: 1 article (04/2014)
2. Sugiuchi, Tomone: 1 article (04/2014)
3. Shimizu, Saki: 1 article (04/2014)
4. Tatara, Ayaka: 1 article (04/2014)
5. Andatsu, Saki: 1 article (04/2014)
6. Miyoshi, Satoshi: 1 article (04/2014)
7. Sato, Maho: 1 article (04/2014)
8. Ohno, Yukihiro: 1 article (04/2014)
9. Castorina, Alessandro: 1 article (03/2012)
10. Leggio, Gian Marco: 1 article (03/2012)

Related Diseases

1. Ocular Hypotension
2. Catalepsy
3. Vomiting
4. Dystonia (Limb Dystonia)
5. Amnesia (Dissociative Amnesia)

Related Drugs and Biologics

1. 7-hydroxy-2-N,N-dipropylaminotetralin
2. Haloperidol (Haldol)
3. Raclopride
4. Quinpirole
5. Scopolamine (Hyoscine)
6. Dopamine (Intropin)
7. Apomorphine
8. AD 6048
9. 1- (2- methoxy- phenyl)- 4- (4- (4- (6- imidazol(2,1- b) thiazolyl)- phenoxy)- butyl- 4- (14)C)- piperazine dimethane
10. SB 277011

Related Therapies and Procedures

1. Sympathectomy (Sympathectomies)